Could a pill shield celiac patients from Gluten's harm?
NCT ID NCT05636293
Summary
This study is testing if a drug called ritlecitinib can protect people with well-managed celiac disease from intestinal damage and symptoms if they accidentally eat gluten. Forty participants will take either the drug or a placebo pill daily while also consuming a small, controlled amount of gluten for three weeks. Researchers will check if the drug helps prevent the immune system from attacking the gut lining and causing symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.